Mitoscreening platform (MSP)
Lausanne
About Mitoscreening platform (MSP)
Mitoscreening platform (MSP) is used to screen metabolism-targeting anti-cancer drugs to discover.
Company Facts
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Total funding: $9.8K
- Last round: Grant (Apr 2019)
Canonical: https://fsome.com/organization/mitoscreening-platform-msp-8325091 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.